CSIMarket


Iovance Biotherapeutics inc   (IOVA)
Other Ticker:  
 

Iovance Biotherapeutics inc

IOVA's Fundamental analysis








Looking into Iovance Biotherapeutics Inc growth rates, revenue grew in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 62

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -1.03 %



More on IOVA's Growth


Iovance Biotherapeutics Inc
realized net loss in trailing twelve months.

Iovance Biotherapeutics Inc realized cash outflow of $ -1.54per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1431.77.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.78.


More on IOVA's Valuation
 
 Total Debt (Millions $) 1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 18.22
 Tangible Book Value (Per Share $) 1.45

Iovance Biotherapeutics Inc
realized net loss in trailing twelve months.

Iovance Biotherapeutics Inc realized cash outflow of $ -1.54per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1431.77.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.78.

Iovance Biotherapeutics Inc Price to Book Ratio is at 4.01 lower than Indusry Avg. of 766.38. and higher than S&P 500 Avg. of 0.01

More on IOVA's Valuation

  Market Capitalization (Millions $) 2,726
  Shares Outstanding (Millions) 266
  Employees -
  Revenues (TTM) (Millions $) 2
  Net Income (TTM) (Millions $) -450
  Cash Flow (TTM) (Millions $) -409
  Capital Exp. (TTM) (Millions $) -21
  Total Debt (Millions $) 1
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 18.22
  Tangible Book Value (Per Share $) 1.45

  Market Capitalization (Millions $) 2,726
  Shares Outstanding (Millions) 266
  Employees -
  Revenues (TTM) (Millions $) 2
  Net Income (TTM) (Millions $) -450
  Cash Flow (TTM) (Millions $) -409
  Capital Exp. (TTM) (Millions $) -21





  Ratio
   Capital Ratio (MRQ) 5.34
  Total Debt to Equity (MRQ) 0
  Tangible Leverage Ratio (MRQ) 0.46
  Asset Turnover Ratio (TTM) 0
  Inventory Turnover Ratio (TTM) 1.54





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com